White Paper

An Experimental Proliferative Vitreoretinopathy (PVR) Model for Testing of New Treatment

The proliferative vitreoretinopathy (PVR) model was successfully induced and demonstrated 28 days after one injection of rabbit conjectunctival fibroblast cells (RCFs). The PVR model is able to test the efficacy of the test articles to discover new treatments
for patients with PVR.